Your shopping cart is currently empty

CAIX/GPX4-IN-1 (Compound 22abcb) is a dual inhibitor targeting the activities of CA IX and GPX4. It effectively kills SUM159PT cells (IC50= 416 nM) under hypoxic conditions by inducing ferroptosis. In SUM159PT-CAIX-FL cells, the IC50 for CA IX is 663 nM. This compound significantly inhibits tumor growth and can be reversed by a ferroptosis inhibitor. CAIX/GPX4-IN-1 is applicable in research on cancers such as breast cancer.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | CAIX/GPX4-IN-1 (Compound 22abcb) is a dual inhibitor targeting the activities of CA IX and GPX4. It effectively kills SUM159PT cells (IC50= 416 nM) under hypoxic conditions by inducing ferroptosis. In SUM159PT-CAIX-FL cells, the IC50 for CA IX is 663 nM. This compound significantly inhibits tumor growth and can be reversed by a ferroptosis inhibitor. CAIX/GPX4-IN-1 is applicable in research on cancers such as breast cancer. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.